|Dr. Ethan Hu|
Dr. Hu has served as a director and the chief financial officer of Frankenman Medical Equipment Limited, a leading surgical device company in China, since 2014. From 2011 to 2014, Dr. Hu worked as a vice president of CITIC PE Investment Limited, a recognized private equity firm in China. Prior to that, Dr. Hu was a principal at Lilly Asian Ventures from 2007 to 2010 and an associate director of Novartis Oncology from 2004 to 2007. Dr. Hu received an MBA degree from the University of Chicago, a Ph.D. degree in molecular and cell biology from the University of Maryland and a bachelor's degree from Peking University.